Search Results - "Mamede, Isadora"

Beyond scalpels: A meta-analysis of robotic and laparoscopic gastrectomy in long-term oncological outcomes in gastric cancer by Silva, Caroliny, Hespanhol, Larissa, Oliveira, João Pedro, Silva, Isadora Mamede Mendes da, Vilbert, Maysa, Araújo-Filho, Irami

“…e16125 Background: Gastric cancer persists as a substantial worldwide health concern, serving as a prominent contributor to both the incidence and fatalities…”
Get full text

Abstract 12281: Association Between Extremely High HDL-C Levels and Mortality: A Systematic Review and Meta-Analysis by Mamede, Isadora, Antonio Pinheiro Braga, Marcelo, Oliveira Franchini, Anne Estefane, Martins, Otavio C, Silveira Filho, Rodrigo B, Catao, Marcel

“…Abstract only Background: Recent research challenges previous findings that linked higher levels of high-density lipoprotein cholesterol (HDL-C) to lower…”
Get full text

Abstract 13202: Efficacy and Safety of Combining a Thiazide Diuretic With a Loop Diuretic in Decompensated Heart Failure: A Systematic Review and Meta-Analysis by Silveira Filho, Rodrigo B, Antonio Pinheiro Braga, Marcelo, Mamede, Isadora, Martins, Otavio C, Oliveira Franchini, Anne Estefane, Catao, Marcel

“…Abstract only Background: Acute decompensated heart failure (ADHF) has several presentations, one of the most common being congestion which is treated by…”
Get full text

Survival and pulmonary function in stage IA non‐small cell lung cancer after sublobar resection versus lobectomy: An updated meta‐analysis by Mamede, Isadora, Ribeiro, Leonardo, Stecca, Carlos, Escalante‐Romero, Lorena, Cypel, Marcelo

“…Traditionally, lobectomy was standard for stage IA non‐small‐cell lung cancer (NSCLC). Recent RCTs suggest sublobar resection's comparable outcomes. Our…”
Get full text

Immunotherapy plus chemotherapy versus chemotherapy alone in perioperative treatment for locally advanced gastric cancer: A systematic review and meta-analysis by Silva, Isadora Mamede Mendes da, Oliveira, João Pedro, Maia, Melissa, de Liz, Caio Dabbous, Oliveira, Audrey Cabral Ferreira de, Alves, Ana Caroline Fonseca

“…e16083 Background: The standard care for locally advanced gastric (LAGC) or gastroesophageal junction (GEJ) cancer is perioperative chemotherapy (CTX) with…”
Get full text

Immune checkpoint inhibitor plus chemotherapy versus chemotherapy alone in HER2-negative advanced gastric or gastroesophageal junction cancer: A systematic review and meta-analysis of randomized controlled trials by Oliveira, João Pedro, Silva, Isadora Mamede Mendes da, de Liz, Caio Dabbous, Maia, Melissa, Oliveira, Audrey Cabral Ferreira de, Alves, Ana Caroline Fonseca

“…e16052 Background: Synergistic effects of immune checkpoint inhibitors (ICI) and chemotherapy (CTX) have been documented, demonstrating promising efficacy…”
Get full text

Two-dimensional facial photography for assessment of craniofacial morphology in sleep breathing disorders: a systematic review by Mamede, Isadora, Lacerda, Sophia Paiva Silveira, Alvares, Alice Veloso, Rodrigues, Anna Barbara Veloso Tomaz, Silva, Bruna de Souza, Andrade, Bruna Oliveira, Martins, Luciana Menezes Nogueira

“…Purpose Craniofacial morphology is integral to Sleep Breathing Disorders (SBD), particularly Obstructive Sleep Apnea (OSA), informing treatment strategies…”
Get full text

Immunotherapy Plus Chemotherapy Versus Chemotherapy Alone as First-Line Treatment for Advanced Urothelial Cancer: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials by Mamede, Isadora, Escalante-Romero, Lorena, Celso, Davi S. Gonçalves, Reis, Pedro C. Abrahao, Dacoregio, Maria Inez, Alves, Ana Caroline, Stecca, Carlos

“…Platinum-based chemotherapy (CTX) has historically been the primary treatment for advanced urothelial cancer (aUC), with limited alternative options. The…”
Get full text

Association between very high HDL-C levels and mortality: A systematic review and meta-analysis by Mamede, Isadora, Braga, Marcelo Antonio Pinheiro, Martins, Otavio C., Franchini, Anne E.O., Silveira Filho, Rodrigo B., Santos, Marcel C.F.

“…•High HDL-C up to 126 mg/dL reduces fatal/non-fatal coronary heart disease events.•No decrease in all-cause mortality compared to normal levels.•Men with HDL-C…”
Get full text